Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Bernstein Remains a Buy on Molina Healthcare (MOH)

Tipranks - Tipranks - Sat Apr 11, 6:02AM CDT

Bernstein analyst Lance Wilkes maintained a Buy rating on Molina Healthcare today and set a price target of $173.00.

Easter Sale - 70% Off TipRanks

Wilkes covers the Healthcare sector, focusing on stocks such as Centene, Cigna, and HCA Healthcare. According to TipRanks, Wilkes has an average return of -8.7% and a 32.67% success rate on recommended stocks.

The word on The Street in general, suggests a Hold analyst consensus rating for Molina Healthcare with a $143.54 average price target.

See today’s best-performing stocks on TipRanks >>

Based on Molina Healthcare’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $11.38 billion and a GAAP net loss of $160 million. In comparison, last year the company earned a revenue of $10.5 billion and had a net profit of $251 million

Based on the recent corporate insider activity of 60 insiders, corporate insider sentiment is neutral on the stock. Last month, Ronna Romney, a Director at MOH sold 506.00 shares for a total of $74,341.52.

Read More on MOH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).